(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
Imaging in cancer therapeutics 2015
1. Imaging in Cancer Therapeutics!
Past, Present and Future!
Parminder S. Basran, PhD, FCCPM
Senior Medical Physicist
BCCA- Vancouver Island Centre
Adjunct Associate Professor
University of Victoria- Dept. Physics & Astronomy
@psbasran
www.slideshare.net/psbasran
!
2. Outline!
• Introduction: What is Cancer?!
• Clinical Example: Lung cancer!
• Challenges!
• Conclusions / Future Directions!
3. Introduction: Cancer!
http://en.wikipedia.org/wiki/Cancer!
“a class of diseases in which a group of cells
display uncontrolled growth, invasion that
intrudes upon and destroys adjacent tissues,
and sometimes metastasis, or spreading to
other locations in the body via lymph or
blood.”!
5. Detection & Screening!
• Not only is imaging used to measure the
extent of the disease, it is commonly used
to screen patients (generally higher risk
patients) to mitigate morbidity from cancer. !
• Breast Cancer / Mammography!
• Colorectal Cancer / CT Colonoscopy
(iScanImaging. “3D Virtual Colonoscopy." Online video clip.
YouTube. YouTube, 18 Apr. 2012. Accessed May 20, 2015)!
6. Individualized Cancer Care!
• As our understanding of cancer increases, so
does the recognition that each tumor is unique.!
• In the last decade, the focus in cancer
research on the genetic make-up of cancer!
• Now it is clear that the tumor
microenvironment, cellular and protein
interactions affect disease progression,
aggressiveness and response to treatment.!
7. Individualized Cancer Care!
Subsequently, imaging the !
• tumor micro-environment!
• host/stem cell interactions,!
• various proteins !
can be used to assess !
• disease progression!
• aggressiveness !
• response to treatment!
10. Patient Consult!
• 70 year old male!
• Smoker for 20 years, quit 2 years ago!
• Painter!
• History of cancer in family!
• Father had prostate cancer!
• Uncle had lung cancer!
Symptoms!
• Coughing starting about 3 years ago, persistent for 2
years but got worse over last year!
• Dull chest pain over the last year!
• Wheezy/hoarsness in breathing !
• Weight loss over the last year!
11. Diagnosis!
Tests that may be performed include:!
• Chest x-ray!
• Sputum cytology test to look for cancer cells!
• Blood work!
13. Staging!
Stage 0 - the cancer has not spread beyond the inner lining of
the lung!
Stage I - the cancer is small and hasn't spread to the lymph
nodes!
Stage II - the cancer has spread to some lymph nodes near the
original tumor!
Stage III - the cancer has spread to nearby tissue or spread to
far away lymph nodes !
Stage IV - the cancer has spread to other organs of the body
such as the other lung, brain, or liver!
14. Staging!
Stage 0 - the cancer has not spread beyond the inner lining of
the lung!
Stage I - the cancer is small and hasn't spread to the lymph
nodes!
Stage II - the cancer has spread to some lymph nodes near the
original tumor!
Stage III - the cancer has spread to nearby tissue or spread to
far away lymph nodes !
Stage IV - the cancer has spread to other organs of the body
such as the other lung, brain, or liver!
15. Prognosis!
Stage! Survival rate
after 5 years!
Treatment!
0 / 1! 80%! Surgery (segmentectomy/wedge resection),
photodynamic therapy, cryotherapy, radiation
therapy!
2! 40-50%! Lobectomy; pneumonectomy; or segmental, wedge !
Radiation therapy, Adjuvant chemotherapy
(Cisplatin) after curative surgery. !
3! 10-23 %! Chemo-radiation therapy for patients with stage IIIA-
N2 disease.!
Radiation therapy alone for patients medically unfit!
4! <10%! Chemotherapy, Radiation for palliative/symptom
relief!
16. Treatment Strategy!
Radiation Therapy!
• Deliver high dose (60 Gy) with multiple
photon beams (6 MeV range)!
• Need to simulate the treatment virtually!
• Obtain a CT scan to define the tumor and
normal tissues!
• Simulate the radiation beams in the CT
dataset!
19. PET-CT!
Positron Emission Tomography (PET), is a non-invasive
molecular imaging technique that uses various radio-labeled
compounds and visualizes metabolic differences between
tissues, thus depicting the functional status of a suspicious
lesion. !
30. Clinical effectiveness, quality
of life and costs!
Has changed the practice of management.!
But challenges remain:!
Challenges: How much?!
31. Tools (WHAT)!
• A better mouse-trap!
• Efficiency vs. efficacy!
• Risks!
• $!
!
Techniques (HOW)!
• When you have a hammer …!
• Diagnosis, Prognosis, Follow-up!
• Clinical Indications!
• Clinical Adoption!
!
Semantics in a Multi-disciplinary world!
!
Challenges in Cancer
Management!
32. Challenges: Example!
Tools (WHAT = DEFORMABLE REGISTRAION) !
• A better mouse-trap : A vendor’s black-box
algorithm!
• Efficiency vs. efficacy !
• Risks : !
• $!
!
Techniques (HOW = USE OF DR in Radiation
Oncology)!
• Diagnosis, Prognosis, Follow-up!
• Clinical Adoption : is there a clinical impact?!
!
!
34. Example: Quantifying the Accuracy
of Deformable Registration!
CATPHAN 600 Phantom Reference CT!
• Scanned at high resolution!
• CT image quality phantom!
• Various testing disks!
Matlab !
• Deformed datasets (CT)!
!
GE Workstation!
• Deformed CT=> Ref CT!
• Registered CT!
!
Matlab!
• Quantitatively examine Reg CT !
• Compare with Ref CT !
35. !
Deformed in Y and Z (2cm)
!
Deformation ranged from 1 – 3 cm!
dY = couch change!
(curved to flat)!
dX = curved spine!
(scoliosis)!
dZ = curved neck!
(chin up/down)!
Combined deformations!
Example: Quantifying the Accuracy
of Deformable Registration!
39. If using deformable registration with GE, consider!
!
1) Contouring errors of at least few mm!
!
2) Image quality is largely retained!
- So suspicious high / low contrast objects are
likely correlated!
3) Patient rotations will cause headaches!
- Especially yaw rotations!
!
!
Example: Quantifying the accuracy
of Deformable Registration!
40. Example: Quantifying the Accuracy
of Deformable Registration (CT-CT)!
!
!
Original CT Dataset!
!
!
!
41. Example: Quantifying the accuracy
of Deformable Registration (CT-CT)!
!
!
Deformed CT Dataset!
!
!
!
42. Example: Quantifying the accuracy of
Deformable Registration (PET-PET)!
!
!
Original PET Dataset!
!
!
!
43. Example: Quantifying the accuracy of
Deformable Registration (PET-PET)!
!
!
Deformed PET Dataset!
!
!
!
44. Conclusions / Future
Considerations!
Bold Prediction (2012)!
Multi-modality imaging will replace ‘gold
standard’ !
• PET-CT is now standard of care for Lung, HN,
Cervical and other cancers (limited only by
availability)!
• MR-PET is now a commercially available
product!